Literature DB >> 9349668

Myosin-induced autoimmune polymyositis in the rat.

T Kojima1, N Tanuma, Y Aikawa, T Shin, A Sasaki, Y Matsumoto.   

Abstract

Experimental autoimmune myositis (EAM) was induced in Lewis rats by immunization with partially purified and purified skeletal myosin. Although clinical signs such as muscle weakness were very mild, multiple inflammatory lesions in the skeletal muscle, but not in the heart, were found by histological examination. Immunohistochemical staining revealed that muscle fiber-infiltrating cells were CD8+ and CD11b+ cells and that CD4+, TCR alphabeta+, B and NK cells were mainly located in the endomysium and interfiber connective tissue. These findings were in contrast to those obtained in experimental autoimmune encephalomyelitis lesions in which CD4+ cells predominate over CD8+ cells. T cells and sera isolated from myosin-immunized animals responded vigorously to myosin. However, neither sensitized lymphoid cells mainly comprising CD4+ cells nor purified anti-myosin immunoglobulin G mediated the disease into naive rats, suggesting that T cells other than CD4+ cells such as CD8+ cells may be the final effector. Taken together, EAM induced in Lewis rats is similar to human polymyositis (PM). EAM can serve as a good model for human PM and give insight into the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349668     DOI: 10.1016/s0022-510x(97)00148-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Development of an improved animal model of experimental autoimmune myositis.

Authors:  Juan Kang; Hong-Ya Zhang; Guo-Dong Feng; Dong-Yun Feng; Hong-Ge Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.

Authors:  Dong Xue Wang; Xin Lu; Ning Zu; Bing Lin; Li Ying Wang; Xiao Ming Shu; Li Ma; Guo Chun Wang
Journal:  Clin Rheumatol       Date:  2012-08-30       Impact factor: 2.980

3.  Role of regulatory T cells in a new mouse model of experimental autoimmune myositis.

Authors:  Yves Allenbach; Sounkary Solly; Sylvie Grégoire; Odile Dubourg; Benoit Salomon; Gillian Butler-Browne; Lucile Musset; Serge Herson; David Klatzmann; Olivier Benveniste
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

4.  A new modified animal model of myosin-induced experimental autoimmune myositis enhanced by defibrase.

Authors:  Luo Wen-Jing; Pu Chuan-Qiang; Li Hong-Hua; Lu Xiang-Hui; Liu Jie-Xiao
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

5.  Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.

Authors:  Hongya Zhang; Fangyuan He; Ming Shi; Wenxiu Wang; Xiaojia Tian; Juan Kang; Wenjuan Han; Rui Wu; Linfu Zhou; Mengmeng Hu; Xiaobo Li; Fang Mi; Gang Zhao; Hongge Jia
Journal:  Front Neurol       Date:  2017-04-12       Impact factor: 4.003

6.  NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis.

Authors:  Ping Xia; Yu-Quan Shao; Cong-Cong Yu; Yu Xie; Zhi-Jie Zhou
Journal:  BMC Immunol       Date:  2022-08-14       Impact factor: 3.594

7.  Beneficial role of rapamycin in experimental autoimmune myositis.

Authors:  Nicolas Prevel; Yves Allenbach; David Klatzmann; Benoit Salomon; Olivier Benveniste
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

8.  Effect of butylphthalide intervention on experimental autoimmune myositis in guinea pigs.

Authors:  Juan Chen; Jingyang Wang; Jiyan Zhang; Chuanqiang Pu
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

9.  Comparison of rapamycin and methylprednisolone for treating inflammatory muscle disease in a murine model of experimental autoimmune myositis.

Authors:  Juan Kang; Dongyun Feng; Feng Yang; Xiaojia Tian; Wenjuan Han; Hongge Jia
Journal:  Exp Ther Med       Date:  2020-05-05       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.